Home World's First Small Nucleic Acid Hair Growth Agent Unveiled: Silan® Pioneers a New Paradigm in Precision Scalp Repair

World's First Small Nucleic Acid Hair Growth Agent Unveiled: Silan® Pioneers a New Paradigm in Precision Scalp Repair

Oct 27, 2025 11:41 CST Updated 11:41
YOUJIA BIO

Nucleic Acid Drug Developer

Image

Meeting Venue


October 26, 2025"World's First"Silan® Small Nucleic Acid Hair Growth AgentDebuted at the exhibition site of the Inaugural Conference of the Hair Medicine Professional Committee of the China Non-Public Medical Institutions Association, drawing significant attention from the industry.


Si Lan®ForShanghai Nuoliangsiyan Biotechnology Co., Ltd.Under its efficacy-oriented scalp repair brand, leveraging the technical accumulation in the field of nucleic acid drugs, the first targeted anti-hair loss and hair growth product has been launched, bringing a new paradigm of precise repair to the field of hair health.


Image

Exhibition Site


SILAN® is a functional scalp repair brand created by Shanghai Nuoliang Siyan Biotechnology Co., Ltd., which is a subsidiary of YOUJIA BIO.


Nolians Yucca is the global pioneer in RNA skincare, adhering to"Technological Innovation, Beautifying You and Me"On a mission, focusing on ribonucleic acid as the bioactive ingredient, concentrating on the industrial directions of functional skincare products and medical devices.


The brand name "SiLAN®" originates from the English term "siRNA," which stands for small interfering ribonucleic acid. Its main products include scalp repair lotion, scalp moisturizing essence, and scalp conditioning shampoo. By utilizing cutting-edge siRNA nucleic acid technology, the company develops anti-hair loss products. It produces cosmetics according to pharmaceutical research and development standards, applying advanced nucleic acid technology to the field of scalp health to create a differentiated competitive advantage.


Image

Exhibition Site


Unlike traditional chemical hair growth products, the core breakthrough of SILAN® Small Nucleic Acid Hair Growth Agent lies in"Precision Targeting"——The R&D team has specifically designed exclusive anti-hair loss targets for the brand, with a targeting accuracy rate exceeding 90%. By precisely addressing the root causes of scalp issues, the product achieves multi-effect synergy in oil control, anti-inflammation, and improving scalp nutrition levels. It not only resolves the core triggers of hair loss but also significantly reduces the risk of side effects due to its precise mechanism of action, offering a safer solution for individuals with sensitive scalps.


Currently, SILAN® has built a diversified promotion matrix, with Xiaohongshu as the core publicity platform, reaching young consumer groups through professional content output; at the same time, it has laid out channels such as Douyin and Tmall flagship stores, forming a complete chain of "content seeding + e-commerce conversion."


With the debut of the first small nucleic acid hair growth agent, Siran® will continue to rely on the technical support of YOUJIA BIO, deepen the application of nucleic acid technology in the field of scalp health, and is expected to launch more precise repair products in the future, injecting innovative vitality into the hair health industry.


From small nucleic acid drug research and development to scalp health care, Siran® is leveraging technological innovation as a fulcrum to pioneer a new paradigm in precise medical hair repair, offering safer and more effective solutions for people experiencing hair loss.

  END 


Follow us

Learn More Health Information


Health Herald | Contributions Invited

If you are skilled in writing health-related articles and familiar with the tone of original articles from Health Herald, we will provide you with a high-quality platform. Let's work together to disseminate health knowledge, speak for medical professionals, and popularize science for the public! We welcome submissions (requirement: original articles that have not been publicly published). Once accepted, generous remuneration will be provided. Contact information is as follows:

Call for PapersEmail:health_media@163.com

Contact Number:010 - 56927858



Previous Recommendations

Image

Congratulations! "Si Lan" Successfully Selected as an Excellent Case for "Telling the Story of Pharmaceuticals in the New Era 2025"

Image

New Breakthrough for Hong Kong and Macao Traditional Chinese Medicine Products in Mainland China Market: "Houzao Chutan San" First to Pass Simplified Approval Process for Launch in Mainland China